Ken Griffin Senseonics Holdings, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$0.5 - $0.73 $30,950 - $45,187	-61,900 Reduced 52.37%	56,300 $29,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $0.7 $13,008 - $18,970	27,100 Added 29.75%	118,200 $67,000
Q3 2023 Nov 14, 2023	SELL	$0.5 - $1.05 $25,350 - $53,235	-50,700 Reduced 35.75%	91,100 $54,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.89 $103,565 - $167,587	-188,300 Reduced 57.04%	141,800 $107,000
Q1 2023 May 15, 2023	BUY	$0.68 - $1.25 $37,264 - $68,500	54,800 Added 19.91%	330,100 $234,000

Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.34 $72,768 - $101,572	75,800 Added 37.99%	275,300 $283,000
Q3 2022 Nov 14, 2022	BUY	$1.02 - $2.23 $19,380 - $42,370	19,000 Added 10.53%	199,500 $263,000

148

66.3M

392K

207K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $186M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.